Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients With Parkinson's Disease

April 20, 2023 updated by: Universidad Francisco de Vitoria

Validation of Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients With Parkinson's Disease: Study Protocol for a Randomized Controlled Trial

Parkinson's disease (PD) is the second most common neurodegenerative disorder. PD is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity. Although balance impairment is characteristic of advanced stages, it can be present with less intensity since the beginning of the disease. Approximately 60% of PD patients fall once a year and 40% recurrently These falls may be correlated with the inability to achieve compensatory movements to regain balance when their center of gravity tends to swing outside their range of stability, which is reduced in this disease. On the other hand, cognitive symptoms affect up to 20% of patients with PD in early stages and can even precede the onset of motor symptoms. There are cognitive requirements for balance and can be challenged when attention is diverted or reduced, linking a worse balance and a higher probability of falls with a slower cognitive processing speed and attentional problems. Cognitive rehabilitation of attention and processing speed can lead to an improvement in postural stability in patients with Parkinson's. The investigators present a parallel and controlled Randomized Clinical Trial (RCT) to assess the impact on balance of a protocol based on cognitive rehabilitation focused on sustained attention through the NeuronUP platform (Neuronup SI, La Rioja, España) in patients with PD. This therapy opens the possibility of new rehabilitation strategies for prevention of falls in PD, reducing morbidity and saving costs to the health system.

Study Overview

Status

Completed

Conditions

Detailed Description

Parkinson's disease (PD) is the second most common neurodegenerative disorder. This disease is characterized by motor symptoms, such as bradykinesia, tremor, and rigidity. Non-motor symptoms such as cognitive impairment, anosmia, sleep disorders, or depression are also part of the disease, and although their prevalence is very high, non-motor symptomsare often underdiagnosed.

One of the cognitive characteristics in PD is the slowness in the processing of information, which includes deficits in processing speed and attention, cognitive inflexibility, and forgetfulness. These symptoms may appear from the initial stages of the disease.

Approximately 60% of PD patients fall once a year and 40% do so regularly. These falls may be correlated with the inability to achieve compensatory movements to regain balance when their center of gravity generally oscillates outside their limits of stability (LOS), which is reduced in this disease. Some authors point out that reaction times and processing speed may be a marker of postural instability since a reduced speed is associated with difficulty in making turns. This is in line with Pantall's findings, indicating that cognitive function and postural control normally progressively worsen with disease progression.

The relationship between cognitive impairment and postural instability in PD patients may be specific for tasks that assess the dorsolateral prefrontal cortex and its frontal-subcortical connections. The main cognitive functions whose affectation would influence a worse balance and gait performance would be attention and executive functions. Varalta et al specified that balance is related to executive functions and attention, while functional mobility is more related to cognitive impairment, verbal fluency, and attentional capacity.

Some authors point out that within the executive functions the component with the greatest weight in this relationship would be the inhibitory control. Dual-task performance has also been established as a good indicator of falls in patients with early-stage PD and no previous history of falls. The studies that carried out a one and a half years follow-up of the participants concluded that the deterioration of executive functions acts as a predictor of future falls in patients with PD.

Cognitive rehabilitation through neurorehabilitation platforms and neuropsychological rehabilitation in patients with Parkinson's disease has shown to be effective in improving processing speed, attention, and executive functions.

Although the relationship between cognitive deficits and postural stability seems to be demonstrated, the investigators have not found studies that, through cognitive rehabilitation, seek a stability improvement.

The investigators working hypothesis is that the group that receives rehabilitation of the speed of information processing and sustained attention will improve their postural stability compared to the group that does not undergo any therapy.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28007
        • Hospital Beata María Ana

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Idiopathic Parkinson's disease (diagnosed according to the UK Parkinson´s Disease Society Brain Bank criteria).
  • Stage <III Hoehn-Yahr with no obvious motor fluctuations.

Exclusion Criteria:

  • Visual-perceptual difficulties.
  • Peripheral sensory disturbances due to polyneuropathy.
  • Cerebellar alterations.
  • Severe cognitive impairment (MoCA <24).
  • Moderate or severe active depression (BDI> 14).
  • Dependence (mRS> 3).
  • Dopaminergic medication changes in the last 30 days.
  • Structural changes MRI Severe comorbidity (cancer, severe COPD ...).
  • Atypicality data for idiopathic PD.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuropsychological rehabilitation
In the experimental group, patients will receive a 12-session neuropsychological rehabilitation protocol that will be carried out over four weeks (3 weekly sessions). The protocol and the number of sessions has been designed by neuropsychologists following the Díez-Cirarda et al. recommendations
The intervention can be carried out in the research unit or in the Parkinson's association. Each session will consist of a series of cognitive stimulation tasks aimed at improving attention, perception and processing speed. These tasks will be applied through the NeuronUp cognitive neurorehabilitation platform to achieve maximum homogeneity and objectivity in their application. The program is programmed and is identical for all patients. Performing tasks through the platform allows us to objectively record the performance of each patient in all tasks.
No Intervention: Control
The control group will not receive any therapy. The participants will be simply evaluated at the same time as the experimental group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Timed stand up and go test score
Time Frame: From Baseline at 5 weeks
The timed "Up and Go" test measures, in seconds, the time it takes a person to get up from a chair, walk a distance of 3 meters, turn, walk back to the chair and sit down again.
From Baseline at 5 weeks
Change in Berg Balance scale score
Time Frame: From Baseline at 5 weeks
Consists of 14 items scored on an ordinal scale of 0 to 4 for a total of 56 points (a higher score indicates lower fall risk). Scale is designed to measure changes in functional standing balance over time. This scale measures the balance skills observed during tasks that involve sitting, standing, and changing positions.
From Baseline at 5 weeks
Change in Stability limits test: The Biodex Stability Limits (LOS) score
Time Frame: From Baseline at 5 weeks
This test is a challenge for the patient when it comes to moving and exercising control over gravity supported on a base. During each test the patient must change their weight to move the cursor from the center of the target to a new point that will flash on the screen and that will change as fast as the slightest movement or deviation is noticed. This same process will be repeated until another nine objectives are achieved. The test dependent variables provided by the machine are the time (seconds) it takes for the subject to complete the test and the directional control value which is the proportion of the distance travelled by the cursor from the center to each target (based on that 100% is a straight line from the center to the intended target). This means that the greater the distance travelled by the subject, the worse their stability.
From Baseline at 5 weeks
Change in Fall risk test score
Time Frame: From Baseline at 5 weeks
During the test, the patient undergoes three attempts of 20 seconds each, beginning with an initial platform mobility setting of 6 and ending with a platform setting of 2 (from least to most mobile), with rest periods ten seconds between each test. The patient stands with feet shoulder-width apart on the midline of the board. At the end of the index test it is calculated according to the degree of instability of the patient with each configuration. Own normative data are applied.
From Baseline at 5 weeks
Finger tapping (FT)
Time Frame: Baseline
The FT task has been used as a measure of motor function. In this task, following the Strauss application guidelines, participants are instructed to press the space bar on the keyboard as quickly as possible and repeatedly with the index finger. Five 10-second attempts are made with the dominant hand. The average time between two consecutive hits in the five trials is the dependent variable.
Baseline
Finger tapping (FT)
Time Frame: At 5 weeks from baseline
The FT task has been used as a measure of motor function. In this task, following the Strauss application guidelines, participants are instructed to press the space bar on the keyboard as quickly as possible and repeatedly with the index finger. Five 10-second attempts are made with the dominant hand. The average time between two consecutive hits in the five trials is the dependent variable.
At 5 weeks from baseline
Simple reaction time (SRT)
Time Frame: Baseline
This task is used as a measure of simple perception and sustained alertness. Participants are instructed to press the left mouse button as fast as possible when the stimulus "+" appears in the center of the screen with a size of 2 cm x 2 cm. The order of appearance is constant for all participants. The task consists of 50 trials that lasted 2-3 minutes.The average time between the stimulus and the response is the dependent variable.
Baseline
Simple reaction time (SRT)
Time Frame: At 5 weeks from baseline
This task is used as a measure of simple perception and sustained alertness. Participants are instructed to press the left mouse button as fast as possible when the stimulus "+" appears in the center of the screen with a size of 2 cm x 2 cm. The order of appearance is constant for all participants. The task consists of 50 trials that lasted 2-3 minutes.The average time between the stimulus and the response is the dependent variable.
At 5 weeks from baseline
Simple task of attention to sustained response time (SRT-SART)
Time Frame: Baseline
This task helps us to measure the inhibitory response strategy. The participants have to press the left mouse button when the stimulus (digits 1-9) appears in the center of the screen and inhibit the response when it appears as the number "3". The task consists of 168 Go trials and 21 No / Go ; the average duration is 4 minutes. The stimuli vary in size between 12 mm and 29 mm.The average time between the stimulus and the response is the dependent variable.
Baseline
Simple task of attention to sustained response time (SRT-SART)
Time Frame: At 5 weeks from baseline
This task helps us to measure the inhibitory response strategy. The participants have to press the left mouse button when the stimulus (digits 1-9) appears in the center of the screen and inhibit the response when it appears as the number "3". The task consists of 168 Go trials and 21 No / Go ; the average duration is 4 minutes. The stimuli vary in size between 12 mm and 29 mm.The average time between the stimulus and the response is the dependent variable.
At 5 weeks from baseline
Choice reaction time (CRT)
Time Frame: Baseline
This task was used as a measure of visual perception decision time and is related to the same processes involved in the SRT plus the processing of the uncertainty about which of the stimuli will appear to the continuation, that is, decisional processing. Participants have to press the left mouse button when a square appears in the center of the screen (4 cm x 4 cm) or press the right button when a circle appears. The task consists of 80 tests with a duration of approximately 3 minutes.The average time between the stimulus and the response is the dependent variable.
Baseline
Choice reaction time (CRT)
Time Frame: At 5 weeks from baseline
This task was used as a measure of visual perception decision time and is related to the same processes involved in the SRT plus the processing of the uncertainty about which of the stimuli will appear to the continuation, that is, decisional processing. Participants have to press the left mouse button when a square appears in the center of the screen (4 cm x 4 cm) or press the right button when a circle appears. The task consists of 80 tests with a duration of approximately 3 minutes.The average time between the stimulus and the response is the dependent variable.
At 5 weeks from baseline
Choice-search reaction time (CRT-Search)
Time Frame: Baseline
This task helps us to measure visual search. Participants have to press the left mouse button when a "Z" appears in a 6-letter sequence or press the right button when it does not appear. Stimuli are classified according to two dimensions: presence/absence of "Z". The task consists of 128 trials that lasted between 5 and 8 minutes. The average time between the stimulus and the response is the dependent variable.
Baseline
Choice-search reaction time (CRT-Search)
Time Frame: At 5 weeks from baseline
This task helps us to measure visual search. Participants have to press the left mouse button when a "Z" appears in a 6-letter sequence or press the right button when it does not appear. Stimuli are classified according to two dimensions: presence/absence of "Z". The task consists of 128 trials that lasted between 5 and 8 minutes. The average time between the stimulus and the response is the dependent variable.
At 5 weeks from baseline
Stroop test
Time Frame: Baseline
The standardized version applied consists of three DIN-A4 size sheets. Each of which contains 100 elements distributed in five columns of 20 elements. On the first sheet (Stroop-P), the words 'RED', 'GREEN' and 'BLUE' appear, arranged at random and printed in black ink, and the examinee must read them. On the second sheet (Stroop C), all the elements have the same shape ('XXXX') but printed in blue, green, or red ink, and the examinee must say out loud what the color of each one is. On the third sheet (Stroop PC), the first sheet words appear printed in the colors of the second, and the examinee must name the color of the ink with which the word is printed, ignoring the meaning. For each of the sheets, the subject has 45 seconds to say as many items as possible. The number of items and errors are counted for each of the conditions
Baseline
Stroop test
Time Frame: At 5 weeks from baseline
The standardized version applied consists of three DIN-A4 size sheets. Each of which contains 100 elements distributed in five columns of 20 elements. On the first sheet (Stroop-P), the words 'RED', 'GREEN' and 'BLUE' appear, arranged at random and printed in black ink, and the examinee must read them. On the second sheet (Stroop C), all the elements have the same shape ('XXXX') but printed in blue, green, or red ink, and the examinee must say out loud what the color of each one is. On the third sheet (Stroop PC), the first sheet words appear printed in the colors of the second, and the examinee must name the color of the ink with which the word is printed, ignoring the meaning. For each of the sheets, the subject has 45 seconds to say as many items as possible. The number of items and errors are counted for each of the conditions
At 5 weeks from baseline
The Bells Test
Time Frame: Baseline
This task is a distractor instrument that requires a horizontal visual examination on a sheet of A4 size. The target stimuli are bell figures and are located in a pseudo-random way, organized in seven columns containing five bells each one. The columns are positioned on the sheet as follows: three on the left side, one in the middle, and three on the right side of the paper.The task is completed when the subject stops her activity. The time of completion of the test, the number of hits and omissions is counted.
Baseline
The Bells Test
Time Frame: At 5 weeks from baseline
This task is a distractor instrument that requires a horizontal visual examination on a sheet of A4 size. The target stimuli are bell figures and are located in a pseudo-random way, organized in seven columns containing five bells each one. The columns are positioned on the sheet as follows: three on the left side, one in the middle, and three on the right side of the paper. The task is completed when the subject stops her activity. The time of completion of the test, the number of hits and omissions is counted.
At 5 weeks from baseline
Trail Making Test
Time Frame: Baseline
It is a measure of combined speed for attention, sequencing, visual and mental searching, as well as motor function. It is made up of two parts: A and B. While part A fundamentally requires visual-perceptual skills, part B requires working memory functioning, as well as skills to change tasks. The task ends when the subject completes the test. The examiner corrects errors during the task, taking the subject to the previous item. The task completion time is measured.
Baseline
Trail Making Test
Time Frame: At 5 weeks from baseline
It is a measure of combined speed for attention, sequencing, visual and mental searching, as well as motor function. It is made up of two parts: A and B. While part A fundamentally requires visual-perceptual skills, part B requires working memory functioning, as well as skills to change tasks. The task ends when the subject completes the test. The examiner corrects errors during the task, taking the subject to the previous item. The task completion time is measured
At 5 weeks from baseline
Digit Span
Time Frame: Baseline
The test is part of the WAIS-III. The examiner reads aloud a series of digits at a rate of one per second and the examinee must repeat this series thereafter in the same order as it was presented (direct digits) or in the reverse order (reverse digits). The test begins with a two-digit series. In each test two series of equal length are read and, if the examinee correctly repeats at least one of the two, the next test is continued in which the series has one digit more than the previous ones. The test ends when the examinee does not pass two series of the same duration. Each of the said series of digits is scored with a point. The sum of the points in each condition (direct and inverse), the sum of both scores and the maximum number of digits said in a series, will be the dependent variables.
Baseline
Digit Span
Time Frame: At 5 weeks from baseline
The test is part of the WAIS-III. The examiner reads aloud a series of digits at a rate of one per second and the examinee must repeat this series thereafter in the same order as it was presented (direct digits) or in the reverse order (reverse digits). The test begins with a two-digit series. In each test two series of equal length are read and, if the examinee correctly repeats at least one of the two, the next test is continued in which the series has one digit more than the previous ones. The test ends when the examinee does not pass two series of the same duration. Each of the said series of digits is scored with a point. The sum of the points in each condition (direct and inverse), the sum of both scores and the maximum number of digits said in a series, will be the dependent variables
At 5 weeks from baseline
FAS Word Fluency
Time Frame: Baseline
In this task, the examinee is asked to produce the most number of words belonging to a restricted category within a limited time (60 seconds). The assessment of verbal fluency is divided into two tests: 1) semantic verbal fluency: where the subject is asked to name all the elements within a given semantic category (animals), and 2) phonological verbal fluency: where the subject has to name all the elements that start with a particular letter (F, A, and S), not being able to say proper names and words derived from others previously said.The number of correct words, the number of perseverations, proper names and derived words in each of the conditions will be accounted
Baseline
FAS Word Fluency
Time Frame: At 5 weeks from baseline
In this task, the examinee is asked to produce the most number of words belonging to a restricted category within a limited time (60 seconds). The assessment of verbal fluency is divided into two tests: 1) semantic verbal fluency: where the subject is asked to name all the elements within a given semantic category (animals), and 2) phonological verbal fluency: where the subject has to name all the elements that start with a particular letter (F, A, and S), not being able to say proper names and words derived from others previously said. The number of correct words, the number of perseverations, proper names and derived words in each of the conditions will be accounted
At 5 weeks from baseline
Processing Speed-Digit Symbol Coding
Time Frame: Baseline
It is a subtest that is part of the Wechsler Adult Intelligence Scale (WAIS-III). It consists of a sheet in which 9 different aligned symbols are presented in the upper part, to which a consecutive number from 1 to 9 has been assigned. In the lower part, numbers from 1 to 9 appear in random order, and below each one of them a blank space in which the examinee must draw the corresponding symbol. The duration of the task is two minutes and the number of hits and errors are quantified
Baseline
Processing Speed-Digit Symbol Coding
Time Frame: At 5 weeks from baseline
It is a subtest that is part of the Wechsler Adult Intelligence Scale (WAIS-III). It consists of a sheet in which 9 different aligned symbols are presented in the upper part, to which a consecutive number from 1 to 9 has been assigned. In the lower part, numbers from 1 to 9 appear in random order, and below each one of them a blank space in which the examinee must draw the corresponding symbol. The duration of the task is two minutes and the number of hits and errors are quantified.
At 5 weeks from baseline
Processing Speed-Symbol Search
Time Frame: Baseline
It is a subtest included in the Wechsler Adult Intelligence Scale (WAIS-III). It consists of several plates in which two symbols are presented and next to them, another set of 5. The person must decide if any of the first two symbols appear in the second group, marking yes or no in the corresponding place. The duration of the task is two minutes and the number of hits and errors are quantified
Baseline
Processing Speed-Symbol Search
Time Frame: At 5 weeks from baseline
It is a subtest included in the Wechsler Adult Intelligence Scale (WAIS-III). It consists of several plates in which two symbols are presented and next to them, another set of 5. The person must decide if any of the first two symbols appear in the second group, marking yes or no in the corresponding place. The duration of the task is two minutes and the number of hits and errors are quantified
At 5 weeks from baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parkinson's Disease Questionnaire 39
Time Frame: Baseline
It is a specific questionnaire for evaluating the health status of Parkinson's patients. It is a multidimensional scale in which the subjects have to affirm one among five answers ordered in categories according to how frequent, due to Parkinson's disease, the patients have experienced the problem defined by each item. The items are grouped into 8 scales and are scored by expressing the sum of the scores for each item as a percentage that can be between 0 and 100%. Higher scores indicate poorer quality of life
Baseline
Parkinson's Disease Questionnaire 39
Time Frame: At 5 weeks from baseline
It is a specific questionnaire for evaluating the health status of Parkinson's patients. It is a multidimensional scale in which the subjects have to affirm one among five answers ordered in categories according to how frequent, due to Parkinson's disease, the patients have experienced the problem defined by each item. The items are grouped into 8 scales and are scored by expressing the sum of the scores for each item as a percentage that can be between 0 and 100%. Higher scores indicate poorer quality of life
At 5 weeks from baseline
Resting EEG
Time Frame: Baseline
The spectral entropy correlation, the coherence and interhemispheric divergence will be analyzed in a 64-channel resting EEG
Baseline
Resting EEG
Time Frame: At 5 weeks from baseline
The spectral entropy correlation, the coherence and interhemispheric divergence will be analyzed in a 64-channel resting EEG
At 5 weeks from baseline
Tapping EEG
Time Frame: Baseline
A 64-channel EEG recording will be made while pressing for 30 seconds. The registration will be independent for each hand, starting with the dominant one. The spectral entropy correlation, the coherence and interhemispheric divergence will be analyzed in a 64-channel tapping EEG
Baseline
Tapping EEG
Time Frame: At 5 weeks from baseline
A 64-channel EEG recording will be made while pressing for 30 seconds. The registration will be independent for each hand, starting with the dominant one. The spectral entropy correlation, the coherence and interhemispheric divergence will be analyzed in a 64-channel tapping EEG
At 5 weeks from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2021

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

July 22, 2022

Study Registration Dates

First Submitted

January 25, 2021

First Submitted That Met QC Criteria

January 25, 2021

First Posted (Actual)

January 29, 2021

Study Record Updates

Last Update Posted (Actual)

April 21, 2023

Last Update Submitted That Met QC Criteria

April 20, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual anonymized participant data will be available to other researchers under request

IPD Sharing Time Frame

Six months at the end of the study

IPD Sharing Access Criteria

Individual anonymized participant data will be available to other researchers under request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Neuropsychological rehabilitation

3
Subscribe